Overall, this study not only confirms the clinical value of PD-1 inhibitors combined with radiation therapy in the treatment of BC, but more importantly, it reveals the predictive role of biomarkers such as EGFR, providing a new theoretical foundation and practical basis for precision medicine in BC. Here, EGFR is linked to breast cancer.